B
Bailard Portfolio holdings
AUM
$4.29B
1-Year Return
18.39%
This Quarter Return
+8.18%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$2.63B
AUM Growth
+$207M
(+8.6%)
Cap. Flow
+$75.6M
Cap. Flow
% of AUM
2.88%
Top 10 Holdings %
Top 10 Hldgs %
28.14%
Holding
809
New
149
Increased
180
Reduced
264
Closed
108
Top Buys
| 1 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
$79.9M |
| 2 |
SPDR Gold Trust
GLD
|
$70.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$67.4M |
| 4 |
iShares Russell 2000 Value ETF
IWN
|
$52.3M |
| 5 |
iShares California Muni Bond ETF
CMF
|
$14.6M |
Top Sells
Sector Composition
| 1 | Technology | 16.56% |
| 2 | Healthcare | 9.33% |
| 3 | Financials | 7.12% |
| 4 | Industrials | 4.71% |
| 5 | Consumer Staples | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
Genworth Financial
GNW
$3.52B
| $126K | ﹤0.01% |
23,900
| – | – |
|
677
Yext
YEXT
$1.1B
| $126K | ﹤0.01% |
+19,290
| New | +$126K |
|
|
NETI
678
DELISTED
Eneti Inc.
NETI
| $119K | ﹤0.01% |
+11,858
| New | +$119K |
|
|
BHR
679
Braemar Hotels & Resorts
BHR
$203M
| $116K | ﹤0.01% |
28,215
-21,000
| -43% | -$86.3K |
|
|
VRN
680
DELISTED
Veren
VRN
| $111K | ﹤0.01% |
15,557
-17,443
| -53% | -$125K |
|
|
PCTI
681
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $94.8K | ﹤0.01% |
22,047
-9,500
| -30% | -$40.9K |
|
|
UNIT
682
Uniti Group
UNIT
$1.59B
| $94K | ﹤0.01% |
17,007
-56,564
| -77% | -$313K |
|
|
SUP
683
DELISTED
Superior Industries International
SUP
| $93.9K | ﹤0.01% |
+22,249
| New | +$93.9K |
|
684
CommScope
COMM
$3.55B
| $93.3K | ﹤0.01% |
12,700
-32,500
| -72% | -$239K |
|
|
NHS
685
Neuberger Berman High Yield Strategies Fund
NHS
$230M
| $92.3K | ﹤0.01% |
10,839
| – | – |
|
686
Caribou Biosciences
CRBU
$174M
| $89.3K | ﹤0.01% |
14,216
-5,484
| -28% | -$34.4K |
|
687
Ocean Power Technologies
OPTT
$90.2M
| $73.7K | ﹤0.01% |
+163,754
| New | +$73.7K |
|
688
Energy Services of America
ESOA
$165M
| $65.5K | ﹤0.01% |
25,300
+2,000
| +9% | +$5.18K |
|
689
Clearside Biomedical
CLSD
$27.2M
| $53.5K | ﹤0.01% |
+47,800
| New | +$53.5K |
|
|
LENZ
690
LENZ Therapeutics
LENZ
$1.2B
| $52.7K | ﹤0.01% |
2,267
-2,204
| -49% | -$51.2K |
|
|
ARC
691
DELISTED
ARC Document Solutions, Inc.
ARC
| $50.7K | ﹤0.01% |
+17,300
| New | +$50.7K |
|
692
Gevo
GEVO
$404M
| $50K | ﹤0.01% |
+26,300
| New | +$50K |
|
693
Evolv Technologies
EVLV
$1.39B
| $48.7K | ﹤0.01% |
+18,800
| New | +$48.7K |
|
|
UBX
694
DELISTED
Unity Biotechnology
UBX
| $48.5K | ﹤0.01% |
17,700
+12,600
| +247% | +$34.5K |
|
695
IonQ
IONQ
$12.4B
| $43.5K | ﹤0.01% |
+12,600
| New | +$43.5K |
|
|
AKLI
696
DELISTED
Akili, Inc. Common Stock
AKLI
| $43K | ﹤0.01% |
38,357
| – | – |
|
697
Banco Santander
SAN
$141B
| $42.4K | ﹤0.01% |
14,362
| – | – |
|
698
Trevi Therapeutics
TRVI
$854M
| $40.9K | ﹤0.01% |
+21,200
| New | +$40.9K |
|
699
Lipocine
LPCN
$15.7M
| $31.9K | ﹤0.01% |
+4,880
| New | +$31.9K |
|
700
Ovid Therapeutics
OVID
$87.5M
| $23.4K | ﹤0.01% |
12,600
+800
| +7% | +$1.49K |
|